Transforming India’s approach to cancer care
In India, a country with a vast population and a diverse socio-economic fabric, healthcare remains fraught with challenges including disparities in access. These socio-economic disparities are deep, and
Cancer
-
Patients win Patent War
It's double trouble for global pharma companies in India. On April 1, a Supreme Court bench comprising Judges Aftab Alam and Ranjana Desai dismissed Swiss drug major Novartis AG's seven-year-old plea seeking
-
No to 'ever-greening'
The Pharmaceutical Research and Manufacturers of America and the United States India Business Council are miffed over the recent Novartis judgment of the Supreme Court (SC) of India. For us, however,
-
Drug dependence
Less is sometimes more. That was the message delivered this week by Meghna Das Thakur of the Novartis Institutes for Biomedical Research, in Emeryville, California, to the American Association for Cancer
-
Steps to rein in Ghaggar pollution as cancer cases up
Fatehabad DC orders pollution check Following a spate of reports about prevalence of cancer in villages adjoining the Ghaggar, allegedly due to its polluted water, Fatehabad Deputy Commissioner (DC) Dr Saket Kumar today asked the officials concerned to find a solution to the problem. Villagers from over six villages had recently apprised Dr Saket Kumar about the alarming trend during his visit to the Ghaggar near Chandpura. The DC had gone there to review flood-control measures in the area.
-
HC notice to UT, Punjab on PIL
The Punjab and Haryana High Court today issued notice to the Centre and authorities in Punjab, Haryana and Chandigarh on a public interest litigation seeking a ban on cancer-causing agents. The PIL claimed there was a nexus between government officials and the industry, due to which carcinogens made their way into the consumer market. “The unholy nexus and collusion between the industry and public servants leads to a situation which results in mortality and morbidity of a large number of people, which is no less than cold-blooded murder,” the PIL filed by Hemant Goswami said.
-
J-K has 56,716 cancer patients
As many as 56,716 cancer patients are registered with the Oncology Department at Government Medical Colleges (GMC) in Jammu and Srinagar, who are undergoing treatment at various stages. As per the data
-
Right to affordable drugs upheld: activists
“The court has recognised the right of patients to access affordable medicines over profits for big pharma companies” It was celebration time for health activists and civil society groups after the Supreme Court delivered its judgment dismissing Swiss multinational company Novartis’ appeal for patent for its anti-cancer medicine imatinib mesylate or Gleevec. “We are happy that the apex court has recognised the right of patients to access affordable medicines over profits for big pharmaceutical companies through patents.
-
‘Cancer incidence in rural areas much lower’
The incidence of cancer in the rural areas in the country is much lower when compared to towns and cities, triggering an interest among experts to study the causes for the phenomenon. While the incidence is 45 per one lakh a year in the rural areas, it is as high as 95-100 per lakh a year in major cities and 70 per lakh a year in midsized towns, according to Rajendra Badwe, Director Tata Memorial Centre, Mumbai.
-
Novartis plea for patent of cancer drug: Supreme Court verdict today
The Supreme Court will pronounce on Monday its verdict in a landmark patent case involving Swiss pharma giant Novartis AG. The company has challenged the denial of patent to its blood cancer drug Glivec in India The verdict, which is crucial even for public health, is being watched closely by global pharmaceutical firms, who have been pushing for stronger patent protection in India to regulate the country's $26-billion generic drug industry.
-
At Mayapuri, junk still threatens life
Three Years After Tragedy, No Mechanism In Place To Check Radioactivity New Delhi: Thirty-fiveyear-old Deepak Jain, a scrap dealer at Mayapuri, doesn’t come to work regularly. Labourers at his shop,